More than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. But there are promising new developments in psychedelic medicine to help treat this debilitating symptom. Guest Dr. James Kuo is a physician and biotech executive with more than 25 years of drug development experience. He is co-founder of Return Heath, the first biotech company developing novel, non-hallucinogenic psychedelic to alter dementia’s progression.